Niagen Bioscience Inc (NASDAQ: NAGE) open the trading on Thursday, with a bit cautious approach as it glided -3.40% to $7.39, before settling in for the price of $7.65 at the close. Taking a more long-term approach, NAGE posted a 52-week range of $2.31-$9.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 16.76%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 18.18%. This publicly-traded company’s shares outstanding now amounts to $77.33 million, simultaneously with a float of $49.23 million. The organization now has a market capitalization sitting at $574.58 million. At the time of writing, stock’s 50-day Moving Average stood at $6.40, while the 200-day Moving Average is $4.77.
Niagen Bioscience Inc (NAGE) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Niagen Bioscience Inc’s current insider ownership accounts for 36.68%, in contrast to 29.21% institutional ownership. According to the most recent insider trade that took place on Mar 07 ’25, this organization’s SVP, General Counsel bought 273 shares at the rate of 7.86, making the entire transaction reach 2,146 in total value, affecting insider ownership by 2,251. Preceding that transaction, on Dec 13 ’24, Company’s Director sold 37,161 for 6.19, making the whole transaction’s value amount to 229,956. This particular insider is now the holder of 244,179 in total.
Niagen Bioscience Inc (NAGE) Earnings and Revenue Records
Niagen Bioscience Inc’s EPS increase for this current 12-month fiscal period is 18.18% and is forecasted to reach 0.20 in the upcoming year.
Niagen Bioscience Inc (NASDAQ: NAGE) Trading Performance Indicators
Let’s observe the current performance indicators for Niagen Bioscience Inc (NAGE). It’s Quick Ratio in the last reported quarter now stands at 3.06. The Stock has managed to achieve an average true range (ATR) of 0.43. Alongside those numbers, its PE Ratio stands at $70.18, and its Beta score is 2.19. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.77. Similarly, its price to free cash flow for trailing twelve months is now 48.32.
In the same vein, NAGE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.11, a figure that is expected to reach 0.02 in the next quarter, and analysts are predicting that it will be 0.20 at the market close of one year from today.
Technical Analysis of Niagen Bioscience Inc (NAGE)
[Niagen Bioscience Inc, NAGE] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 26.42% While, its Average True Range was 0.42.
Raw Stochastic average of Niagen Bioscience Inc (NAGE) in the period of the previous 100 days is set at 68.54%, which indicates a major rise in contrast to 7.54% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 26.12% that was lower than 118.91% volatility it exhibited in the past 100-days period.
